{
  "ptid_time": "068_S_5146_2013-05-15",
  "img_path": "/data/qiuhui/data/adni/images/068_S_5146/2013-05-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 23,917 mm³, 14.8% below the reference mean. With a Z-score of -0.34 (36.7th percentile), this represents normal volume ; hippocampal volume measures 6,501 mm³, 8.6% below the reference mean. With a Z-score of -0.79 (21.4th percentile), this represents normal volume ; whole brain volume measures 969,908 mm³, 0.5% below the reference mean. With a Z-score of -0.06 (47.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,026 mm³, 17.6% below the reference mean. With a Z-score of -1.08 (14.0th percentile), this represents mild atrophy; fusiform gyrus volume measures 15,464 mm³, 9.1% below the reference mean. With a Z-score of -0.83 (20.4th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,578 mm³, 2.1% above the reference mean. With a Z-score of 0.19 (57.3th percentile), this represents normal volume . ",
  "text_data": "Age is 72.9 years. Gender is Female. Education: 18 years. MMSE: 25.0. MoCA: 23.0. Logical Memory: 0.0. Biomarker levels: Florbetapir (AV45): 1.42 SUVR (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements show mostly normal values, with mild atrophy in the entorhinal cortex. Cognitive test scores (MMSE 25, MoCA 23) are slightly below typical cutoffs for normal cognition but not strongly indicative of dementia. Elevated AV45 (amyloid PET) suggests amyloid pathology, increasing Alzheimer's risk.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, early Alzheimer's trajectory)  \n**Confidence:** **Medium** (cognitive scores borderline, amyloid supports progression risk, but structural atrophy is not yet severe)",
  "timestamp": "2025-07-26T09:03:33.361533"
}